Press release -
Vironova in panel discussion on cell and gene therapy (Boston)
Vironova is participating in a panel discussion at the Cell and Gene Therapy Bioprocessing and Commercialization conference in Boston, represented by Nina Forsberg, Marketing Director.
The session is based on a new e-book ”Key Consideration in Gene Therapy Manufacturing for Commercialization” published by Cell Culture DISH, and our participation in a collaboration to create it. Nina Forsberg, Marketing Director and Josefina Nilsson, Head of Business Unit, EM Services are co-authors.
The panel discussion covers gene therapy manufacturing and the latest in manufacturing methods, analytical analysis and key regulatory considerations, including:
- Planning for scale up, technology transfer and regulatory considerations on the way to commercialization.
- In-house vs. Outsourcing manufacturing.
- Ensuring scalability and efficient timelines in manufacturing while still maintaining reasonable cost.
- Incorporating the right analytics in gene therapy manufacturing
- Where we are at as an industry and where there is room for improvement
Related links
Topics
- Medical research
Categories
- vironova
Vironova is a Swedish biotechnology company providing comprehensive, hardware, software and services for the analysis of nanoparticles. Vironova revolutionizes access to transmission electron microscopy (TEM)-based image analysis in biopharmaceutical development. Our solution enables automated analyses for faster and better-informed decisions to secure robust bioprocessing and final product quality.
The Vironova offering comprises:
- Cost effective, fast Electron Microscopy (EM) services enabled by the in-house developed Vironova Analyzing Software (VAS) designed for semi-automated nanoparticle analysis
- Viral clearance testing performed in GLP and BSLIII certified laboratories
- MiniTEM™, a bench-top Transmission Electron Microscope system designed for automated nanoparticle characterization. High-resolution images reveal particle morphologies that are transformed into accurate metrics.
